BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2019 11:18:56 AM | Browse: 1311 | Download: 2477
 |
Received |
|
2019-09-27 09:55 |
|
Peer-Review Started |
|
2019-09-27 09:55 |
|
First Decision by Editorial Office Director |
|
2019-11-10 05:44 |
|
Return for Revision |
|
2019-11-10 05:44 |
|
Revised |
|
2019-11-30 07:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-12-06 07:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-12-06 22:17 |
|
Articles in Press |
|
2019-12-06 22:17 |
|
Edit the Manuscript by Language Editor |
|
2019-12-10 01:44 |
|
Typeset the Manuscript |
|
2019-12-13 06:24 |
|
Publish the Manuscript Online |
|
2019-12-14 11:18 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Tailored eradication vs empirical bismuth-containing quadruple therapy as first-line Helicobacter eradication: A comparative, open trial
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Youn I Choi, Jun Won Chung, Dong Kyun Park, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim and Ja Young Seo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jun Won Chung, MD, PhD, Associate Professor, Doctor, Doctor, Division of Gastroenterology, Department of Internal Medicine, Gachon University, Gil Medical Center, 21, Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, South Korea. junwonchung@hanmail.net |
| Key Words |
Helicobacter pylori; Eradication; Tailored; Empirical; Quadruple; |
| Core Tip |
Few studies have compared the efficacy and safety profile of a tailored eradication (TR) strategy based on the presence of a 23S ribosomal RNA point mutation with those of empirical bismuth-based quadruple therapy (EBQT) as first-line eradication for Helicobacter pylori infection in Korean patients.
In this prospective, open-label, comparative study results, the first-line eradication rate of H. pylori did not statistically differ between the strategy of TR and EBQT. However, the rate of eradication-related side effects was significantly lower in TR than EBQT strategy.
TR H. pylori eradication using DPO-PCR may be equally efficacious, with less treatment-related complications, compared to EBQT in Korea, where clarithromycin resistance is high. |
| Publish Date |
2019-12-14 11:18 |
| Citation |
Choi YI, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, Seo JY. Tailored eradication vs empirical bismuth-containing quadruple therapy as first-line Helicobacter eradication: A comparative, open trial. World J Gastroenterol 2019; 25(46): 6743-6751
|
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i46/6743.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i46.6743 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
